Trial Profile
A Randomised, Multi-Centre Study to Compare the Efficacy and Safety of Extended Release Quetiapine Fumarate (Seroquel XR TM) Tablets as Mono-Therapy or in Combination With Lithium in the Treatment of Patients With Acute Bipolar Depression.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Lithium
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- Acronyms QUALITY
- 28 Jun 2012 Actual patient number changed from 488 to 421 according to ClinicalTrials.gov.
- 10 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.